Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV

Funded by the National Institute on Drug Abuse as a Center of Excellence

Learn about us Publications & Presentations Subscribe
Center for Health Economics of Treatment for Substance Users Is Established at Weill Cornell Medical College Read more

Abuse Deterrent Opioids: A Hard Sell

by Benjamin Ukert, PhD

One strategy to combat the opioid epidemic is to change the formulation of opioids to deter abuse. Reformulations can make opioids harder or less pleasant to inject, snort, or chew, thereby reducing common methods of abuse. Since 2010, the FDA has approved 10 opioid abuse deterrent formulations, which are considerably more expensive than regular brand […]

Read the blog post

Although evidence from health policy research should inform policymaking, researchers and policymakers don’t always communicate. A conference sponsored by the Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV (CHERISH) – a NIDA-funded Center of Excellence – and hosted by the Leonard Davis Institute of Health Economics (LDI) sought to […]

Read the blog post

A recent statistical brief from the Agency for Healthcare Research and Quality (AHRQ) provides valuable information regarding patient characteristics for opioid-related inpatient stays and emergency department (ED) visits in the US and within 44 states and the District of Columbia. The brief comes from AHRQ’s Healthcare Cost and Utilization Project (HCUP), which is the largest […]

Read the blog post

The National Institute on Drug Abuse estimates that substance use disorders, comprising illicit drugs and alcohol use as well as smoking, cost the United States more than $740 billion per year. This includes the cost of crime, incarceration, lost productivity, and medical care. A recent study considered the economic consequences of heroin use specifically, finding […]

Read the blog post

In response to the growing opioid epidemic in the United States there is an increased focus on expanding evidence-based treatment using medications prescribed for substance use disorder, especially medications that can be prescribed in outpatient settings including buprenorphine and naltrexone. The Surgeon General’s report on facing addiction in America describes substance use disorders as chronic […]

Read the blog post


The Upshot: A Helpful Tool to Combat the Opioid Crisis

Austin Frakt, a health economist, describes the role of prescription drug monitoring programs in the opioid epidemic. He spoke with CHERISH Dissemination and Policy Core Director Dr. Zachary Meisel and cites several studies by CHERISH Pilot Grantee Dr. Yuhua Bao.


Experts in cost benefit, cost effectiveness, and budget impact analyses

Learn More Consultation Request


Experts in economic analysis of HCV and HIV and treatment among substance users

Learn More Consultation Request

Dissemination and Policy

Experts in disseminating health economic research among policy makers and the public

Learn More Latest Issue Brief

Pilot Grant and Training

Supports new investigators and investigators new to health economic research in substance use disorders, HCV, and HIV

Learn More Pilot Grants